Net sales as a percent of gross sales are generally below 50% for traditional products due primarily to higher government rebates. Government programs experienced rapid growth resulting in an increase in the percentage of total retail prescription drug costs from 20% in 2000 to over 50% in 2021.

By attending this virtual course, you'll learn about:

• Medicare Part B buy & bill provider reimbursement and GTN implications
• White, brown and clear bagging
• Medicare Part D Prescription Drug Program
• Considerations for estimating Medicare Part D Donut Hole
• Fundamentals of Medicaid Drug Rebate Program
• Implications of price increases on Medicaid Net Price and GTN
• Triggering Medicaid best price penalty
• Medicaid penny pricing
• Authorized generics
• TRICARE
• 340B – ecosystem, double dipping and current developments
• Medicaid enacted legislation
• Implications of the Build Back Better Act